Advertisement

Microarray and immunoassay company Aushon BioSystems Inc. of Billerica said it has signed a diagnostic development collaboration letter of intent with Peking University Cancer Hospital (PUCH) in Beijing.

The two aim to develop predictive diagnostic markers for liver metastases of colorectal cancer using Aushon’s protein biomarker detection technologies and stratification biomarkers for radio-chemotherapy patients.

SOURCE

Advertisement
Advertisement